Co-Diagnostics Inc

CODX

Company Profile

  • Business description

    Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company’s technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.

  • Contact

    2401 South Foothill Drive
    Salt Lake CityUT84109
    USA

    T: +1 801 438-1036

    https://www.codiagnostics.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2026

    Employees

    132

Stocks News & Analysis

stocks

Lowering profit forecasts on Aussie airlines

The impact of the oil price surge.
stocks

AI isn’t an economic moat killer, but it will disrupt industries

How we’re rethinking companies’ competitive advantages in an AI-first world.
stocks

AI lands a blow on some Aussie stocks – yet stands to benefit others

AI is reshaping ASX tech moats - but some are more insulated than others.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,592.90103.70-1.19%
CAC 407,726.2060.580.79%
DAX 4022,653.86273.671.22%
Dow JONES (US)46,208.47631.001.38%
FTSE 1009,894.1524.18-0.24%
HKSE24,731.42348.951.43%
NASDAQ21,946.76299.151.38%
Nikkei 22551,840.82325.330.63%
NZX 50 Index12,701.75197.97-1.53%
S&P 5006,581.0074.521.15%
S&P/ASX 2008,401.90102.70-1.21%
SSE Composite Index3,838.2124.930.65%

Market Movers